Citi Pharma raises Rs2.32 billion in over-subscribed IPO
KARACHI: Citi Pharma has raised Rs2.32 billion in an over-subscribed book-building process of the company’s Initial Public Offering (IPO), according to the Topline Securities, adviser and book runner of the issue. “The IPO received an overwhelming response from institutional investors and high networth individuals, as the strike price clocked in at Rs32/share, 14.3 per cent … Read more